(YTEN) |
| 0 (0%) 04-14 05:00 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 48.18 |
| Resistance 1: | 41.25 |
| Pivot price: | 38.97 |
| Support 1: | 36.49 |
| Support 2: | 33.54 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 3.160 |
| Book Value | 62.480 |
| PEG Ratio | 0.00 |
| Gross Profit | 15.001 |
| Profit Margin (%) | 20.15 |
| Operating Margin (%) | 36.56 |
| Return on Assets (ttm) | 3.9 |
| Return on Equity (ttm) | 9.1 |
Company news
Thu, 24 Apr 2025
YTEN Stock Price, News & Analysis - Stock Titan
Tue, 10 Dec 2024
YTEN Price History for Yield10 Bioscience Stock - Barchart
Fri, 30 Aug 2024
From data theft to ransomware: threats and protection in the financial sector - DB.com
Wed, 17 Jul 2024
Yield10 Bioscience Grants Nufarm a Commercial License to Omega-3 Assets for Producing Oil in Camelina, and Yield10 and Nufarm sign a Memorandum of Understanding for Sale of Assets - Stock Titan
Wed, 15 May 2024
Yield10 Bioscience Announces Delisting from Nasdaq - Yahoo Finance
Mon, 01 Apr 2024
YTEN Stock Earnings: Yield10 Bioscience Beats EPS for Q4 2023 - InvestorPlace
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
